Consonance Capital Management LP 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 1:57 pm Sale | 2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Consonance Capital Management LP | 0 0.000% | -2,729,709 (Position Closed) | Filing |
| 2021-02-17 2:23 pm Sale | 2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Consonance Capital Management LP | 2,729,709 6.380% | -3,328,796 (-54.94%) | Filing |
| 2021-02-16 2:22 pm Purchase | 2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Consonance Capital Management LP | 6,058,505 9.990% | 6,058,505 (New Position) | Filing |